| Timothy W Herrick, MD | |
|
91 Camp St, Hyannis, MA 02601-3006 | |
| (508) 790-5955 | |
| Not Available |
| Full Name | Timothy W Herrick |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 41 Years |
| Location | 91 Camp St, Hyannis, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356308555 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RP1001X | Internal Medicine - Pulmonary Disease | 161154 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Cape Cod Healthcare | Hyannis, MA | Hospital |
| Falmouth Hospital | Falmouth, MA | Hospital |
| Entity Name | Physicians Of Falmouth Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821363698 PECOS PAC ID: 6800051970 Enrollment ID: O20120625000127 |
News Archive
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the second quarter ended June 30, 2010.
Pfizer's announcement on Monday that its COVID-19 shot appears to keep nine in 10 people from getting the disease sent its stock price rocketing. Many news reports described the vaccine as if it were our deliverance from the pandemic, even though few details were released.
The COVID-19 pandemic presents new challenges for clinicians caring for infected patients with diabetes, according to new guidance published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk patients.
› Verified 2 days ago
| Entity Name | Physicians Of Cape Cod Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679832364 PECOS PAC ID: 9638326671 Enrollment ID: O20120828000193 |
News Archive
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the second quarter ended June 30, 2010.
Pfizer's announcement on Monday that its COVID-19 shot appears to keep nine in 10 people from getting the disease sent its stock price rocketing. Many news reports described the vaccine as if it were our deliverance from the pandemic, even though few details were released.
The COVID-19 pandemic presents new challenges for clinicians caring for infected patients with diabetes, according to new guidance published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk patients.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy W Herrick, MD 91 Camp St, Hyannis, MA 02601-3006 Ph: (508) 790-5955 | Timothy W Herrick, MD 91 Camp St, Hyannis, MA 02601-3006 Ph: (508) 790-5955 |
News Archive
Dyadic International, Inc., a global biotechnology company focused on the discovery, development, manufacture and sale of specialty enzyme products and solutions for the bioenergy, industrial enzyme and biopharmaceutical industries, today announced financial results for the second quarter ended June 30, 2010.
Pfizer's announcement on Monday that its COVID-19 shot appears to keep nine in 10 people from getting the disease sent its stock price rocketing. Many news reports described the vaccine as if it were our deliverance from the pandemic, even though few details were released.
The COVID-19 pandemic presents new challenges for clinicians caring for infected patients with diabetes, according to new guidance published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism.
In the largest such study so far undertaken, US researchers have shown that testosterone replacement slows the recurrence of prostate cancer in low-risk patients.
› Verified 2 days ago
Mary W Crowell, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1030 Falmouth Rd, Hyannis, MA 02601 Phone: 774-470-5080 | |
Dr. Lawrence Bradley Pliss, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 91 Camp Street, Hyannis, MA 02601 Phone: 508-790-5955 Fax: 508-775-8654 | |
Cormac Francis Coyle, MD Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 433 West Main St, Hyannis, MA 02601 Phone: 508-778-4777 Fax: 508-771-9555 | |
Sheila Maier, D.O. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1030 Falmouth Rd Ste 201, Hyannis, MA 02601 Phone: 774-470-5080 | |
Sarita Bajracharya, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 22 Lewis Bay Rd, Hyannis, MA 02601 Phone: 508-862-5562 | |
Dr. Natalie Ann Mariano, M.D. Pulmonary Disease Medicare: Not Enrolled in Medicare Practice Location: 145 Falmouth Rd, Hyannis, MA 02601 Phone: 508-771-3190 Fax: 508-771-0940 | |
Dr. Philip N Chiotellis, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 52 Park St, Hyannis, MA 02601 Phone: 508-771-8804 Fax: 508-790-9453 |